Navigation Links
Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
Date:5/10/2013

tion, have additional recommendations or change their guidance or requirements before or after approval; data and other information related to any of Arena's research and development may not meet safety, efficacy or other regulatory requirements or otherwise be sufficient for further research and development, regulatory review or approval or continued marketing; Arena's ability to obtain and defend patents; the timing, success and cost of Arena's research and development programs; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies may not proceed at the time or in the manner expected or at all; having adequate funds; and satisfactory resolution of litigation or other disagreements with others. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.Contact: Arena Pharmaceuticals, Inc.

Media Contact: Russo PartnersCindy McGee, Vice President,

David Schull, PresidentInvestor Relations & Alliance Management

david.schull@russopartnersllc.comcmcgee@arenapharm.com

858.717.2310858.453.7200, ext. 1479
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BIOCOM Applauds Arena Pharmaceuticals Commitment to Innovation, Contributions to Southern California Life Science Community
2. Carena Launches 24/7 Virtual Care Delivery Service for Hospital Systems and Primary Care Clinics
3. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
4. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2
5. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
6. Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
7. Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
8. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, March 4
9. Proposed Regulatory Uniformity to Boost Venture Capital Investments in Healthcare Arena, Says Frost & Sullivan
10. Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
11. Arena Pharmaceuticals and Ildong Pharmaceutical Enter Into Co-Development and License Agreement for Temanogrel, a Novel Agent for Thrombotic Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... y LONDRES, August 29, 2015 ... para los sistemas de imagen por Ultrasonidos ... Ecografía, tiempos de examen rápidos y un flujo de ... confianza diagnóstica en el proceso de detección de Cardiopatías ... PHIA) ha anunciado hoy el lanzamiento europeo de ...
(Date:8/28/2015)... According to a new market ... Prostate) Type (Protein & Genetic Biomarkers) Profiling Technology (Proteomics, ... Geography - Global Forecast to 2020", published by MarketsandMarkets, ... 17,689.0 Million USD by 2020 at a CAGR of ... Browse 191 Tables and 38 F ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Tobramycin is a traditional antibiotic whose eye drop ... the treatment of potential infection or inflammation caused by ... China are able to produce tobramycin, among ...
Breaking Medicine Technology:Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5Investigation Report on China's Tobramycin Market, 2015-2019 2
... NEW YORK, Sept. 27 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... Chief Executive Officer, will be presenting at the JMP Securities ... in New York City.  Mr. Bentsur,s presentation is scheduled to ... A live audio webcast of Mr. Bentsur,s presentation ...
... Mass., Sept. 25 Boston Scientific Corporation (NYSE: ... data from the HORIZONS-AMI trial.  The trial, sponsored ... support from Boston Scientific and The Medicines Company ... determine the safety and efficacy of the TAXUS® ...
Cached Medicine Technology:Keryx Biopharmaceuticals to Present at JMP Securities Healthcare Conference 2HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients 2HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients 3HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients 4
(Date:8/31/2015)... ... 31, 2015 , ... Wyoming Medical Center, an acute care ... Clinical Documentation Improvement (CDI) and medical coding needs. Based on a proprietary Natural ... is an enterprise-level coding solution that combines CDI, Coding, Quality and Compliance Auditing ...
(Date:8/31/2015)... CA (PRWEB) , ... August 31, 2015 , ... Castle ... to the practice. Dr. Pedram Ghasri is a graduate of the University of California, ... and continued his studies at the University of California, Irvine Medical School. As a ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... “My mother ... said an inventor, from Hagerhill, Ky. “I thought there could be a comfortable way ... Protector. , The Nasal Cannula Ear Protector offers a more secure way to anchor ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... A year ... the team is preparing to release a new issue commemorating the successful first year. ... information they need for a potentially difficult time in their lives,” says Melissa Wolfert, ...
(Date:8/31/2015)... Los Angeles, ACA (PRWEB) , ... August 31, 2015 , ... ... filling a growing niche in the digital healthcare industry. , Consumer driven health ... the field: one in an advisory and strategic role to the company, and another ...
Breaking Medicine News(10 mins):Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 3Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 4Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 3Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 3
... ago, a large biotech company began collecting ePRO ... tablet system in clinical trials around the world. ... using the assisTek system compared to what it ... traditional paper questionnaires. The results showed that assisTek,s ...
... led the University of California, San Francisco for the past 10 years, ... 2009. , ... (Vocus) October, 24, 2008 -- Chancellor J. Michael Bishop, ... past 10 years, today announced plans to step down from his post, ...
... including free sessions -- is,now open at ... This November, the,international grassroots organization, Children ... 20th annual,international conference at the Anaheim Hilton, ... an exceptional opportunity to connect,with parents, teachers, ...
... With the,number of visitors to Internet drug outlets nearly ... is higher than ever. Based on its,assessment of more ... Association of Boards of Pharmacy(R) (NABP(R)) finds,that 97% of ... with state,and federal laws or established patient safety and ...
... Oct. 23 Halloween can be,filled with tricks and ... The California Poison Control System (CPCS) urges parents to ... while,decreasing risk., If parents have questions, the CPCS ... a week for immediate expert help and information in,case ...
... Oct. 23 LifeSync Corporation,announced it has entered ... comprised of 12,000 members in 20 states, for ... ECG LeadWear(R) products., Shelley Hartman, President of ... this agreement with MAGNET. MAGNET is a major ...
Cached Medicine News:Health News:assisTek's ePRO Biotech Clinical Trial Data Collection Saves Client $1.6 Million Over Paper Questionnaires 2Health News:UCSF Chancellor J. Michael Bishop Announces Plan To Step Down 2Health News:UCSF Chancellor J. Michael Bishop Announces Plan To Step Down 3Health News:UCSF Chancellor J. Michael Bishop Announces Plan To Step Down 4Health News:UCSF Chancellor J. Michael Bishop Announces Plan To Step Down 5Health News:UCSF Chancellor J. Michael Bishop Announces Plan To Step Down 6Health News:UCSF Chancellor J. Michael Bishop Announces Plan To Step Down 7Health News:CHADD to Host International Conference on AD/HD in Anaheim, CA; Olympian Bruce Jenner to Keynote 2Health News:NABP Findings Underscore Dangers of Purchasing Prescription Medicine Online and From Foreign Sources 2Health News:NABP Findings Underscore Dangers of Purchasing Prescription Medicine Online and From Foreign Sources 3Health News:Celebrate Halloween Safely This Year With Tips From the California Poison Control System 2
... new generation of posterior stabilized knee ... the following: Patellar flange mates with ... machined condyles assure precise, repeatable kinematics ... and patella to reduce wear. Constant ...
... total knee prosthesis stems from many years ... and manufacturing technologies have been used in ... well as a favorable pressure distribution pattern ... wear to a minimum. The inherent design ...
The Balanced Knee System provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results....
... Knee System provides anatomical replacement of all ... preserving the stabilizing Anterior and Posterior Ligaments, ... of the knee. All the components in ... and are equally proportioned and contoured to ...
Medicine Products: